Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia

Annals of Hematology

Volumn 91, Issue 10, 2012, Pages 1623-1631

  Xu, Shu Qian ^a   Wang, Chun Yan ^a,b   Zhu, Xiao Juan ^a,c   Dong, Xiao Yuan ^a   Shi, Yan ^a   Peng, Jun ^a,d   Qin, Ping ^a   Sun, Jian Zhi ^a   Guo, Chengshan ^b   Ni, Heyu ^e   Hou, Ming ^a,d  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d BEIJING HOSPITAL   (China)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

CTLA 4 Ig; Dendritic cells; Immune thrombocytopenia; Indoleamine 2,3 dioxygenase

Indexed keywords

CD123 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; KYNURENINE; MESSENGER RNA; PROSTAGLANDIN E2; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDOLEAMINE 2,3 DIOXYGENASE GENE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR PATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; T-LYMPHOCYTES; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84867334960     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1451-0     Document Type: Article

References (28)

1. McMillan R (2007) The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 44(4 suppl 5):S3-S11
2. Shimizu T, Nomiyama S, Hirata F, Hayaishi O (1978) Indoleamine 2,3-dioxygenase: purification and some properties. J Biol Chem 253(13):4700-4706
3. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9(10):1069-1077
4. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196(4):459-468
5. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22(5):633-642
6. Zhu L, Ji F, Wang Y, Liu Q, Zhang JZ, Matsushima K, Cao Q, Zhang Y (2006) Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J Immunol 177(11):8226-8233
7. Munn DH, Mellor AL, Rossi M, Young JW (2005) Dendritic cells have the option to express IDO-mediated suppression or not. Blood 105(6):2618
8. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, Broide DH, Carson DA, Raz E (2004) Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114 (2):270-279
9. Lee KM, Chuang E, Griffin M, Khattri R, Hong DK, Zhang W, Straus D, Samelson LE, Thompson CB, Bluestone JA (1998) Molecular basis of T cell inactivation by CTLA-4. Science 282 (5397):2263-2266
10. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC et al (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3(11):1097-1101
11. Munn DH, Sharma MD, Mellor AL (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 172:4100-4110
12. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113 (11):2386-2393
13. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R et al (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297(5588):1867-1870
14. Jonuleit H, Kühn U, Müller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum free conditions. Eur J Immunol 27(12):3135-3142
15. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30(9):e36
16. Ware RE, Howard TA (1993) Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. Blood 82(7):2137-2142
17. Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH (2007) Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117(9):2570-2582
18. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):232386-232393
19. Wang CY, Shi Y, Min YN, Zhu XJ, Guo CS, Peng J, Dong XY, Qin P, Sun JZ, Hou M (2011) Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia. J Clin Immunol 31(4):643-649
20. King NJ, Thomas SR (2007) Molecules in focus: indoleamine 2,3- dioxygenase. Int J Biochem Cell Biol 39(12):2167-2172
21. Semple JW, Milev Y, Cosgrave D et al (1996) Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet Tcell reactivity. Blood 87(10):4245-4254
22. Hwu P, Du MX, Lapointe R, Do M, TaylorMW, Young HA (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164 (7):3596-399
23. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4 (10):762-774
24. Sukati H, Watson HG, Urbaniak SJ, Barker RN (2007) Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood 109 (10):4528-4538
25. Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, Freewan M, Stocker R (2007) Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 282:23778-23787
26. Mellor AL, Baban B, Chandler P et al (2003) Cutting edge: induced indoleamine 2,3-dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171(4):1652-1655
27. Liu B, Zhao H, PoonMC, Han Z, Gu D, XuM, Jia H, Yang R, Han ZC (2007) Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 78(2):139-143
28. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752-6761